Pharmacokinetics, Safety and Tolerability of Rotigotine Transdermal Patch in Healthy Japanese and Caucasian Subjects

被引:0
|
作者
Willi Cawello
Seong R. Kim
Marina Braun
Jan-Peer Elshoff
Junji Ikeda
Tomoo Funaki
机构
[1] UCB Pharma,
[2] Otsuka Pharmaceutical Co. Ltd.,undefined
来源
关键词
Japanese Subject; Rotigotine; Caucasian Subject; Dopamine Receptor Agonist; Patch Application;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:95 / 105
页数:10
相关论文
共 50 条
  • [31] Pharmacokinetics, Pharmacodynamics, Pharmacogenomics, Safety, and Tolerability of Avatrombopag in Healthy Japanese and White Subjects
    Nomoto, Maiko
    Pastino, Gina
    Rege, Bhaskar
    Aluri, Jagadeesh
    Ferry, Jim
    Han, David
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (02): : 188 - 195
  • [32] A comparison of the Pharmacokinetics of sarizotan in healthy Japanese and Caucasian subjects
    Krösser, S.
    Wolna, P.
    Kovar, A.
    MOVEMENT DISORDERS, 2006, 21 : S464 - S465
  • [33] MULTIPLE-DOSE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF APROCITENTAN, A DUAL ENDOTHELIN RECEPTOR ANTAGONIST, IN HEALTHY JAPANESE AND CAUCASIAN SUBJECTS.
    Sidharta, P.
    Dingemanse, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S43 - S44
  • [34] Pharmacokinetics and safety of sirukumab following a single subcutaneous administration to healthy Japanese and Caucasian subjects
    Zhuang, Yanli
    Xu, Zhenhua
    de Vries, Dick E.
    Wang, Qingmin
    Shishido, Akira
    Comisar, Craig
    Ford, Joyce A.
    Keen, Monica
    Achira, Meguru
    Tsukamoto, Yuko
    Petty, Kevin J.
    Davis, Hugh M.
    Zhou, Honghui
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (03) : 187 - 199
  • [35] PHARMACOKINETICS AND SAFETY OF ABT-981 IN CHINESE, JAPANESE, AND CAUCASIAN HEALTHY SUBJECTS.
    Kosloski, M. P.
    Liu, W.
    Jiang, P.
    Levesque, M. C.
    Medema, J. K.
    Dutta, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S70 - S71
  • [36] A study of the pharmacokinetics and safety of recombinant activated factor VII in healthy Caucasian and Japanese subjects
    Fridberg, MJ
    Hedner, U
    Roberts, HR
    Erhardtsen, E
    BLOOD COAGULATION & FIBRINOLYSIS, 2005, 16 (04) : 259 - 266
  • [37] Comparison of the pharmacokinetics, pharmacodynamics and tolerability of tezosentan between caucasian and Japanese subjects
    Dingemanse, J
    Gunawardena, KA
    van Giersbergen, PLM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (04) : 405 - 413
  • [38] Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of apixaban in healthy Japanese male subjects
    Yamahira, Naomi
    Frost, Charles
    Fukase, Hiroyuki
    Yu, Zhigang
    Wang, Jessie
    Pursley, Janice
    LaCreta, Frank
    Hiraoka, Masaki
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (07) : 564 - 573
  • [39] Pharmacokinetics, Safety, and Tolerability of Glecaprevir and Pibrentasvir in Healthy White, Chinese, and Japanese Adult Subjects
    Lin, Chih-Wei
    Dutta, Sandeep
    Ding, Bifeng
    Wang, Tianli
    Zadeikis, Neddie
    Asatryan, Armen
    Kort, Jens
    Campbell, Andrew
    Podsadecki, Thomas
    Liu, Wei
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (12): : 1616 - 1624
  • [40] Tigecycline Pharmacokinetics, Tolerability, Safety, and Effect on Intestinal Microflora in Healthy Japanese Male Subjects
    Yamashita, Noriaki
    Matschke, Kyle
    Gandhi, Ashesh
    Korth-Bradley, Joan
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (05): : 513 - 519